The Clorox Company (NYSE:CLX) Holdings Lessened by Parsifal Capital Management LP

Parsifal Capital Management LP trimmed its holdings in shares of The Clorox Company (NYSE:CLX) by 25.4% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 693,788 shares of the company’s stock after selling 236,071 shares during the quarter. Clorox makes up 7.7% of Parsifal Capital Management LP’s holdings, making the stock its 5th biggest holding. Parsifal Capital Management LP’s holdings in Clorox were worth $113,025,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the business. Prospera Private Wealth LLC bought a new position in Clorox during the 3rd quarter valued at about $27,000. Innealta Capital LLC bought a new position in Clorox during the 2nd quarter valued at about $30,000. Trifecta Capital Advisors LLC grew its holdings in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares during the last quarter. Quarry LP grew its holdings in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the last quarter. Finally, Family Firm Inc. bought a new position in Clorox during the 2nd quarter valued at about $31,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. JPMorgan Chase & Co. upped their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday, October 11th. DA Davidson upped their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and upped their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Finally, Evercore ISI lowered their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Five analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, Clorox has a consensus rating of “Hold” and an average price target of $155.00.

Insider Transactions at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.57% of the company’s stock.

Clorox Stock Up 0.3 %

CLX opened at $167.08 on Wednesday. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.35. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The company has a fifty day moving average of $163.18 and a two-hundred day moving average of $149.90. The stock has a market capitalization of $20.68 billion, a price-to-earnings ratio of 58.22, a PEG ratio of 3.08 and a beta of 0.42.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the previous year, the company earned $0.49 earnings per share. The firm’s revenue for the quarter was up 27.0% on a year-over-year basis. On average, research analysts expect that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.92%. Clorox’s dividend payout ratio is currently 170.03%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.